BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30172911)

  • 1. Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma.
    Itou RA; Uyama N; Hirota S; Kawada N; Wu S; Miyashita S; Nakamura I; Suzumura K; Sueoka H; Okada T; Hatano E; Tsutsui H; Fujimoto J
    Hum Pathol; 2019 Jan; 83():77-89. PubMed ID: 30172911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
    Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
    Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
    Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells.
    Okamoto K; Tajima H; Ohta T; Nakanuma S; Hayashi H; Nakagawara H; Onishi I; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Harada S; Wakayama T; Iseki S
    Int J Oncol; 2010 Nov; 37(5):1251-9. PubMed ID: 20878072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
    Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
    Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
    J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Analysis for the Prevalence of Cancer-Associated Fibroblasts in Resected Specimens of Intrahepatic Cholangiocarcinoma is a Simple and Reliable Evaluation System.
    Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
    Ann Surg Oncol; 2023 Sep; 30(9):5420-5428. PubMed ID: 37222943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma.
    Hu J; Xu H; Ma X; Bai M; Zhou Y; Miao R; Wang F; Li X; Cheng B
    Am J Pathol; 2024 Jul; 194(7):1388-1404. PubMed ID: 38670529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts.
    Yamanaka T; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Hagiwara K; Gantumur D; Handa T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Shirabe K
    Br J Cancer; 2020 Mar; 122(7):986-994. PubMed ID: 32015511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
    Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
    Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
    Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
    Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.
    Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N
    Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression.
    Hu S; Xia C; Zou H; Ren W; Liu L; Wang L; Kang Q; He K; Wang T; Zhang X
    Dig Liver Dis; 2023 Aug; 55(8):1114-1125. PubMed ID: 36586771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
    Toshida K; Itoh S; Harada N; Morinaga A; Yugawa K; Tomiyama T; Kosai-Fujimoto Y; Tomino T; Kurihara T; Nagao Y; Morita K; Oda Y; Yoshizumi T
    Cancer Sci; 2023 Mar; 114(3):937-947. PubMed ID: 36369960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts in papillary thyroid carcinoma.
    Zhu L; Zhang X; Zhang S; Zhang Q; Cao L; Zhang Y; Wang D; Liang X; Wu W; Wu S; Jiang R; Liu Y; Zhao X; Zhou G; Xu K; Meng Z
    Clin Exp Med; 2023 Oct; 23(6):2209-2220. PubMed ID: 36715834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
    Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
    Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.